Novel imaging techniques in staging oesophageal cancer

Kieran Foley; John Findlay; Vicky Goh

doi:10.1016/j.bpg.2018.11.009

Novel imaging techniques in staging oesophageal cancer

Kieran Foley, John Findlay, Vicky Goh

Cancer Imaging

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

130 Downloads (Pure)

Abstract

The survival of oesophageal cancer is poor as most patients present with advanced disease. Radiological staging of oesophageal cancer is complex but is fundamental to clinical management. Accurate staging investigations are vitally important to guide treatment decisions and optimise patient outcomes. A combination of baseline computed tomography (CT), endoscopic ultrasound (EUS) and positron emission tomography (PET) are currently used for initial treatment decisions. The potential value of these imaging modalities to re-stage disease, monitor response and alter treatment is currently being investigated. This review presents an essential update on the accuracy of oesophageal cancer staging investigations, their use in re-staging after neo-adjuvant therapy and introduces evolving imaging techniques, including novel biomarkers that have clinical potential in oesophageal cancer.

Original language	English
Journal	BEST PRACTICE AND RESEARCH CLINICAL GASTROENTEROLOGY
Early online date	22 Nov 2018
DOIs	https://doi.org/10.1016/j.bpg.2018.11.009
Publication status	E-pub ahead of print - 22 Nov 2018

Keywords

Oesophageal cancer
TNM
staging
response
prognosis
computed tomography
endoscopic ultrasound
positron-emission tomography
magnetic resonance imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bpg.2018.11.009

Novel imaging techniques in_FOLEY_Firstonline22November2018_GREEN AAM (CC BY-NC-ND)Accepted author manuscript, 1.78 MBLicence: CC BY-NC-ND

Cite this

@article{3d620f0d586546a2a7796b52ea31769b,

title = "Novel imaging techniques in staging oesophageal cancer",

abstract = "The survival of oesophageal cancer is poor as most patients present with advanced disease. Radiological staging of oesophageal cancer is complex but is fundamental to clinical management. Accurate staging investigations are vitally important to guide treatment decisions and optimise patient outcomes. A combination of baseline computed tomography (CT), endoscopic ultrasound (EUS) and positron emission tomography (PET) are currently used for initial treatment decisions. The potential value of these imaging modalities to re-stage disease, monitor response and alter treatment is currently being investigated. This review presents an essential update on the accuracy of oesophageal cancer staging investigations, their use in re-staging after neo-adjuvant therapy and introduces evolving imaging techniques, including novel biomarkers that have clinical potential in oesophageal cancer.",

keywords = "Oesophageal cancer, TNM, staging, response, prognosis, computed tomography, endoscopic ultrasound, positron-emission tomography, magnetic resonance imaging",

author = "Kieran Foley and John Findlay and Vicky Goh",

year = "2018",

month = nov,

day = "22",

doi = "10.1016/j.bpg.2018.11.009",

language = "English",

journal = "BEST PRACTICE AND RESEARCH CLINICAL GASTROENTEROLOGY",

issn = "1521-6918",

publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - Novel imaging techniques in staging oesophageal cancer

AU - Foley, Kieran

AU - Findlay, John

AU - Goh, Vicky

PY - 2018/11/22

Y1 - 2018/11/22

N2 - The survival of oesophageal cancer is poor as most patients present with advanced disease. Radiological staging of oesophageal cancer is complex but is fundamental to clinical management. Accurate staging investigations are vitally important to guide treatment decisions and optimise patient outcomes. A combination of baseline computed tomography (CT), endoscopic ultrasound (EUS) and positron emission tomography (PET) are currently used for initial treatment decisions. The potential value of these imaging modalities to re-stage disease, monitor response and alter treatment is currently being investigated. This review presents an essential update on the accuracy of oesophageal cancer staging investigations, their use in re-staging after neo-adjuvant therapy and introduces evolving imaging techniques, including novel biomarkers that have clinical potential in oesophageal cancer.

AB - The survival of oesophageal cancer is poor as most patients present with advanced disease. Radiological staging of oesophageal cancer is complex but is fundamental to clinical management. Accurate staging investigations are vitally important to guide treatment decisions and optimise patient outcomes. A combination of baseline computed tomography (CT), endoscopic ultrasound (EUS) and positron emission tomography (PET) are currently used for initial treatment decisions. The potential value of these imaging modalities to re-stage disease, monitor response and alter treatment is currently being investigated. This review presents an essential update on the accuracy of oesophageal cancer staging investigations, their use in re-staging after neo-adjuvant therapy and introduces evolving imaging techniques, including novel biomarkers that have clinical potential in oesophageal cancer.

KW - Oesophageal cancer

KW - TNM

KW - staging

KW - response

KW - prognosis

KW - computed tomography

KW - endoscopic ultrasound

KW - positron-emission tomography

KW - magnetic resonance imaging

U2 - 10.1016/j.bpg.2018.11.009

DO - 10.1016/j.bpg.2018.11.009

M3 - Article

SN - 1521-6918

JO - BEST PRACTICE AND RESEARCH CLINICAL GASTROENTEROLOGY

JF - BEST PRACTICE AND RESEARCH CLINICAL GASTROENTEROLOGY

ER -

Novel imaging techniques in staging oesophageal cancer

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this